AbbVie Humira, Pfizer/BioNTech COVID-19 shot may not make top 10 pharma drugs in 2024, with Novo Nordisk Ozempic and ...

China NMPA approves Sanofi & Regeneron’s Dupixent as an add-on maintenance treatment for adults with uncontrolled COPD: Paris Monday, September 30, 2024, 11:00 Hrs [IST] The Nat ...

The National Medical Products Administration approved Dupixent as an add-on maintenance treatment for adults with ...

Sanofi and Regeneron have celebrated a pair of positive clinical trials in inflammatory skin disorders with blockbuster immunology therapy Dupixent that could both lead to new indications for the ...

USA Today reports on how the former president benefitted after a diagnosis that just years prior would have been terminal. Cancer therapies have enabled him to celebrate his 100th birthday this week.

Barclays analyst Carter Gould maintained a Buy rating on Regeneron (REGN – Research Report) today and set a price target of $1,220.00.

China's manufacturing activity slightly improved in September 2024 from August's six-month low, surpassing expectations. However, services activity slowed, missing market forecasts and..

Former PM Ehud Olmert confirms Israel's role in the 2008 killing of Hezbollah's Mughniyeh, breaking 16-year silence on covert Syria mission. The Mitvim Institute's 2024 Foreign Policy Index ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...

Meta Fined $102M for Storing Facebook Passwords in Plain Text ...

The Greek discovery of Iceland more than one thousand years prior to the Vikings is supported by evidence published recently in The Housman Society Journal. Based on an essentially linguistic ...